This cohort study examines whether there are differences associated with retest effects in longitudinal cognitive testing and whether accounting for retesting would alter estimated treatment effects in the Aging and Cognitive Health Evaluation in Elders trial.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Blood Biomarkers to Detect Alzheimer Disease in Primary and Secondary Care | 0 | 5.63 | 15-10-2024 |
| 2 | Association Between Slow-Wave Sleep Loss and Incident Dementia | 0 | 12.27 | 01-12-2023 |
| 3 | White Matter Hyperintensities in Alzheimer Disease | 0 | 6.14 | 01-12-2023 |
| 4 | Cognitive Outcomes After Catheter Ablation for Atrial Fibrillation | 0 | 8.06 | 31-07-2026 |
| 5 | Predictive Models for Cognitive Decline Assessment [version 1; peer review: awaiting peer review] | 0 | 8.8 | 22-07-2026 |
| 6 | Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment | 0 | 14.88 | 14-07-2026 |
| 7 | Impact of Physical and Smart Cognitive Games on Cognitive Performance in Older Adults: A Randomized Controlled Trial | 0 | 5 | 14-07-2026 |
| 8 | Effects of COVID-19 social restrictions on prevalence of age-related disorders and risk factor analyses: Evidence from a two-stage study | 0 | 5 | 14-07-2026 |
| 9 | Serum GFAP Dynamics, Disease Progression, and Therapy Response in MS | 0 | 8.04 | 03-08-2026 |